热门资讯> 正文
Guardant Health在United Health覆盖Shield测试后股价上涨
2026-07-01 23:36
- Guardant Health (GH) is up ~7% in Wednesday morning trading after UnitedHealth Group (UNH) said it would cover the company's blood-based cancer screening test, Guardant Shield, starting Aug. 1.
- The test is used to screen for colorectal cancer.
- Citi analyst Patrick Donnelly said the move is "another positive catalyst for Shield as this expansion of the covered patient opportunity unlocks a new cohort of volumes and should drive significant ASP benefits."
More on Guardant Health
- Guardant Health, Inc. (GH) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
- Guardant Health: Reveal And Shield Driving The Next Growth Phase
- Guardant Health, Inc. (GH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
- Guardant rated new Outperform at RBC on catalysts, growth prospects
- HHS indicates skepticism on international cancer risk assessments
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。